PLASMA CONCENTRATION OF LEVODOPA IN PATIENTS WITH PARKINSONS-DISEASE - RESPONSE TO ADMINISTRATION OF LEVODOPA ALONE OR COMBINED WITH A DECARBOXYLASE INHIBITOR AND CLINICAL CORRELATIONS

被引：48

作者：

RINNE, UK ^{[1
]}

SONNINEN, V ^{[1
]}

SIIRTOLA, T ^{[1
]}

机构：

[1] UNIV TURKU,DEPT NEUROL,TURKU 20520,FINLAND

来源：

EUROPEAN NEUROLOGY | 1973年 / 10卷 / 05期

关键词：

D O I：

10.1159/000114285

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：301 / 310

页数：10

共 50 条

[1] COMPARISON OF DOPA DECARBOXYLASE INHIBITOR (CARBIDOPA) COMBINED WITH LEVODOPA AND LEVODOPA ALONE IN PARKINSONS-DISEASE
LIEBERMAN, A
GOODGOLD, A
JONAS, S
LEIBOWITZ, M
[J]. NEUROLOGY, 1975, 25 (10) : 911 - 916
[2] COMPARISON OF DOPA DECARBOXYLASE INHIBITOR (CARBIDOPA) COMBINED WITH LEVODOPA AND LEVODOPA ALONE ON CARDIOVASCULAR-SYSTEM OF PATIENTS WITH PARKINSONS-DISEASE
LEIBOWITZ, M
LIEBERMAN, A
[J]. NEUROLOGY, 1975, 25 (10) : 917 - 921
[3] COMPARISON OF EFFECTS OF LEVODOPA AND COMBINATION OF LEVODOPA AND A DECARBOXYLASE INHIBITOR IN PARKINSONS-DISEASE
SCHNEIDER, E
FISCHER, PA
JACOBI, P
MAXION, H
[J]. ARCHIV FUR PSYCHIATRIE UND NERVENKRANKHEITEN, 1973, 217 (01): : 95 - 112
[4] DEPRENYL (SELEGILINE) COMBINED WITH LEVODOPA AND A DECARBOXYLASE INHIBITOR IN THE TREATMENT OF PARKINSONS-DISEASE
PRESTHUS, J
HAJBA, A
[J]. ACTA NEUROLOGICA SCANDINAVICA, 1983, 68 : 127 - 133
[5] RESPONSES OF PLASMA LEVODOPA TO TREATMENT WITH LEVODOPA ALONE OR COMBINED WITH A DECARBOXYLASE INHIBITOR
RINNE, UK
SONNINEN, V
SIIRTOLA, T
[J]. ACTA NEUROLOGICA SCANDINAVICA, 1976, 54 (01): : 114 - 114
[6] YEARS COMPARISON OF TREATMENT OF PATIENTS WITH PARKINSONS-DISEASE WITH LEVODOPA COMBINED WITH CARBIDOPA VERSUS TREATMENT WITH LEVODOPA ALONE
MARSDEN, CD
PARKES, JD
REES, JE
[J]. LANCET, 1973, 2 (7844): : 1459 - 1462
[7] URINARY-EXCRETION OF MONOAMINES AND THEIR METABOLITES IN PATIENTS WITH PARKINSONS-DISEASE - RESPONSE TO LONG-TERM TREATMENT WITH LEVODOPA ALONE OR IN COMBINATION WITH A DOPA DECARBOXYLASE INHIBITOR AND CLINICAL CORRELATIONS
SIIRTOLA, T
SONNINEN, V
RINNE, UK
[J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 1975, 78 (02) : 77 - 88
[8] LEVODOPA ALONE AND IN COMBINATION WITH A PERIPHERAL DECARBOXYLASE INHIBITOR BENSERAZIDE (MADOPAR) IN TREATMENT OF PARKINSONS-DISEASE - CONTROLLED CLINICAL TRIAL
RINNE, UK
BIRKETSMITH, E
DUPONT, E
HANSEN, E
HYYPPA, M
MARTTILA, R
MIKKELSEN, B
PAKKENBERG, H
PRESTHUS, J
[J]. JOURNAL OF NEUROLOGY, 1975, 211 (01) : 1 - 9
[9] COMPARATIVE CLINICAL INVESTIGATION OF THE THERAPEUTIC EFFECT OF LEVODOPA ALONE AND IN COMBINATION WITH A DECARBOXYLASE INHIBITOR (CARBIDOPA) IN CASES OF PARKINSONS-DISEASE
WAJSBORT, J
DORNER, A
WAJSBORT, E
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 1978, 5 (09) : 695 - 708
[10] EFFECT OF DURATION OF LEVODOPA DECARBOXYLASE INHIBITOR THERAPY ON THE PHARMACOKINETIC HANDLING OF LEVODOPA IN ELDERLY PATIENTS WITH IDIOPATHIC PARKINSONS-DISEASE
BOWES, SG
ONEILL, CJA
NICHOLSON, PW
LEEMAN, AL
DESHMUKH, AA
DOBBS, RJ
DOBBS, SM
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 41 (05) : 459 - 462

← 1 2 3 4 5 →